Furthermore, the use of antidiabetic medications that mitigate acute glucose variations, such as glinides, alpha-glucosidase inhibitors, and DPP-4 inhibitors, as well as those that enhance insulin sensitivity, including thiazolidinediones and metformin, are anticipated to positively influence endothelial function in patients with DM. The gene discussed is GAA; the disease is diabetes mellitus.